In vitro and in vivo evaluation of pterostilbene for the management of diabetic complications
Background: Aldose reductase (AR) and Advanced glycation end product (AGE) are known to play important roles in the development of diabetic complications. The inhibitors of AR and AGE would be potential agents for the prevention of diabetic complications. Objective: The present study was aimed to ev...
Main Authors: | Dilip Dodda, Ajmera Rama Rao, Ciddi Veeresham |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-10-01
|
Series: | Journal of Ayurveda and Integrative Medicine |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S0975947617302875 |
Similar Items
-
Aldose Reductase: An Emerging Target for Development of Interventions for Diabetic Cardiovascular Complications
by: Sravya Jannapureddy, et al.
Published: (2021-03-01) -
Dietary aldose reductase inhibitors and prevention of diabetic complications
by: Ameena Anjum, et al.
Published: (2021-01-01) -
Development of Novel Indole-Based Bifunctional Aldose Reductase Inhibitors/Antioxidants as Promising Drugs for the Treatment of Diabetic Complications
by: Lucia Kovacikova, et al.
Published: (2021-05-01) -
Inhibition behaviours of some phenolic acids on rat kidney aldose reductase enzyme: an in vitro study
by: Zuhal Alim, et al.
Published: (2017-01-01) -
Research progress on the roles of aldose reductase in diabetic retinopathy
by: Hong-Zhe Li, et al.
Published: (2015-07-01)